Hotte S - Search Results

1

A multicentre analysis of abiraterone acetate in Canadian patients with metastatic castration-resistant prostate cancer.

Clayton R, Wu J, Heng DY, North SA, Emmenegger U, Hotte S, Chi K, Zielinski R, Al-Shamsi H, Chen L, Eigl B. Clayton R, et al. Among authors: hotte s. Can Urol Assoc J. 2014 Sep;8(9-10):E583-90. doi: 10.5489/cuaj.1891. Can Urol Assoc J. 2014. PMID: 25295126 Free PMC article.

2

A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer.

Chi KN, Ellard SL, Hotte SJ, Czaykowski P, Moore M, Ruether JD, Schell AJ, Taylor S, Hansen C, Gauthier I, Walsh W, Seymour L. Chi KN, et al. Among authors: hotte sj. Ann Oncol. 2008 Apr;19(4):746-51. doi: 10.1093/annonc/mdm554. Epub 2007 Dec 3. Ann Oncol. 2008. PMID: 18056648 Free article. Clinical Trial.

3

A phase I study of OGX-011, a 2'-methoxyethyl phosphorothioate antisense to clusterin, in combination with docetaxel in patients with advanced cancer.

Chi KN, Siu LL, Hirte H, Hotte SJ, Knox J, Kollmansberger C, Gleave M, Guns E, Powers J, Walsh W, Tu D, Eisenhauer E. Chi KN, et al. Clin Cancer Res. 2008 Feb 1;14(3):833-9. doi: 10.1158/1078-0432.CCR-07-1310. Clin Cancer Res. 2008. PMID: 18245546 Clinical Trial.

4

Interleukin-2 in the treatment of unresectable or metastatic renal cell cancer: a systematic review and practice guideline.

Hotte S, Waldron T, Canil C, Winquist E. Hotte S, et al. Can Urol Assoc J. 2007 Mar;1(1):27-38. doi: 10.5489/cuaj.34. Can Urol Assoc J. 2007. PMID: 18542758 Free PMC article.

5

Interferon-alfa in the treatment of patients with inoperable locally advanced or metastatic renal cell carcinoma: a systematic review.

Canil C, Hotte S, Mayhew LA, Waldron TS, Winquist E. Canil C, et al. Among authors: hotte s. Can Urol Assoc J. 2010 Jun;4(3):201-8. doi: 10.5489/cuaj.853. Can Urol Assoc J. 2010. PMID: 20514286 Free PMC article.

6

A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer.

Sridhar SS, Canil CM, Chi KN, Hotte SJ, Ernst S, Wang L, Chen EX, Juhasz A, Yen Y, Murray P, Zwiebel JA, Moore MJ. Sridhar SS, et al. Among authors: hotte sj. Cancer Chemother Pharmacol. 2011 Apr;67(4):927-33. doi: 10.1007/s00280-010-1389-7. Epub 2010 Jul 3. Cancer Chemother Pharmacol. 2011. PMID: 20602233 Clinical Trial.

7

Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancer.

Chi KN, Hotte SJ, Yu EY, Tu D, Eigl BJ, Tannock I, Saad F, North S, Powers J, Gleave ME, Eisenhauer EA. Chi KN, et al. Among authors: hotte sj. J Clin Oncol. 2010 Sep 20;28(27):4247-54. doi: 10.1200/JCO.2009.26.8771. Epub 2010 Aug 23. J Clin Oncol. 2010. PMID: 20733135 Clinical Trial.

8

A phase 2 study of patupilone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Canadian Urologic Oncology Group study P07a.

Chi KN, Beardsley E, Eigl BJ, Venner P, Hotte SJ, Winquist E, Ko YJ, Sridhar SS, Weber D, Saad F. Chi KN, et al. Among authors: hotte sj. Ann Oncol. 2012 Jan;23(1):53-58. doi: 10.1093/annonc/mdr336. Epub 2011 Jul 16. Ann Oncol. 2012. PMID: 21765178 Free article. Clinical Trial.

9

A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer.

Beardsley EK, Hotte SJ, North S, Ellard SL, Winquist E, Kollmannsberger C, Mukherjee SD, Chi KN. Beardsley EK, et al. Among authors: hotte sj. Invest New Drugs. 2012 Aug;30(4):1652-9. doi: 10.1007/s10637-011-9722-5. Epub 2011 Jul 23. Invest New Drugs. 2012. PMID: 21785998 Clinical Trial.

10

Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06c.

Saad F, Hotte S, North S, Eigl B, Chi K, Czaykowski P, Wood L, Pollak M, Berry S, Lattouf JB, Mukherjee SD, Gleave M, Winquist E; Canadian Uro-Oncology Group. Saad F, et al. Among authors: hotte s. Clin Cancer Res. 2011 Sep 1;17(17):5765-73. doi: 10.1158/1078-0432.CCR-11-0859. Epub 2011 Jul 25. Clin Cancer Res. 2011. PMID: 21788353 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

184 results

Search Page